SCHEMBL21022692

SCHEMBL21022692

Cn1cccc1-c1cccc(-c2cccnc2)n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.69
ALDH1A1 P00352 2/20 0.69
CYP2A13 Q16696 1/20 0.69
CYP2C9 P11712 3/20 0.45
CYP2C19 P33261 3/20 0.45
CYP2E1 P05181 2/20 0.45
CYP2B6 P20813 2/20 0.45
CYP19A1 P11511 2/20 0.45
CYP3A4 P08684 4/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
PTK2 Q05397 1/20 0.43
KARS1 Q15046 1/20 0.42
HK1 P19367 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nicotyrine SCHEMBL2996756 0.82 CYP2A6 (1.00) CYP2A6ALDH1A1CYP2A13CYP2C9CYP2C19
Nicotyrine SCHEMBL29398389 0.82 CYP2A6 (1.00) CYP2A6ALDH1A1CYP2A13CYP2C9CYP2C19
SCHEMBL439225 0.82 KDM4E (0.49) CYP2A6ALDH1A1CYP2A13HSD17B10NPC1
SCHEMBL3194702 0.80 CYP2A6 (0.74) CYP2A6ALDH1A1CYP19A1CYP3A4CYP1A2
SCHEMBL12925581 0.75 CYP2A6 (0.67) CYP2A6ALDH1A1CYP2C9CYP2C19CYP2E1
SCHEMBL18905222 0.75 CYP19A1 (0.69) CYP2A6ALDH1A1CYP19A1CYP3A4CYP1A2
Nicotyrine SCHEMBL6845683 0.74 ALDH1A1 (0.65) CYP2A6ALDH1A1CYP2A13CYP2C9CYP2C19
SCHEMBL14297284 0.73 CYP2A6 (0.65) CYP2A6ALDH1A1CYP2C9CYP2C19CYP2E1
SCHEMBL10031168 0.73 CYP2A6 (0.65) CYP2A6ALDH1A1CYP2C9CYP2C19CYP2E1
SCHEMBL2460181 0.72 PPARA (0.64) CYP2A6ALDH1A1CYP2A13HSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168103-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-11-09 US disclosed
US-20190153009-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190153009-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES CHRM4, CHRM1, OPRD1 CYP2A6 727/4885ALDH1A1 2688/4885CYP2A13 1516/4885
US-11168103-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OR10J3 CYP2A6 3287/4885ALDH1A1 716/4885CYP2A13 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.